Related references
Note: Only part of the references are listed.Prospects for Prophylactic and Therapeutic Vaccines Against Hepatitis C Virus
Stephen M. Feinstone et al.
CLINICAL INFECTIOUS DISEASES (2012)
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
Dennis R. Burton et al.
SCIENCE (2012)
Hepatitis C virus host cell entry
Alexander Ploss et al.
CURRENT OPINION IN VIROLOGY (2012)
In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus
Philip Meuleman et al.
HEPATOLOGY (2011)
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
Michael Houghton
IMMUNOLOGICAL REVIEWS (2011)
Immunization of Human Volunteers With Hepatitis C Virus Envelope Glycoproteins Elicits Antibodies That Cross-Neutralize Heterologous Virus Strains
Zania Stamataki et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
Jean-Christophe Meunier et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A smouldering public-health crisis
Lauren Gravitz
NATURE (2011)
HEPATITIS IN 2010 The dawn of a new era in HCV therapy
Sandra Ciesek et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Assembly of infectious hepatitis C virus particles
Ralf Bartenschlager et al.
TRENDS IN MICROBIOLOGY (2011)
Neutralizing Antibody Response to Hepatitis C Virus
Yong Wang et al.
VIRUSES-BASEL (2011)
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
William O. Osburn et al.
GASTROENTEROLOGY (2010)
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
Ranjit Ray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies
Judith M. Gottwein et al.
JOURNAL OF VIROLOGY (2010)
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
Sharon E. Frey et al.
VACCINE (2010)
Development and Characterization of Hepatitis C Virus Genotype 1-7 Cell Culture Systems: Role of CD81 and Scavenger Receptor Class B Type I and Effect of Antiviral Drugs
Judith M. Gottwein et al.
HEPATOLOGY (2009)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
Zania Stamataki et al.
VACCINE (2007)
Tracking Virus-Specific CD4+T Cells during and after Acute Hepatitis C Virus Infection
Michaela Lucas et al.
PLOS ONE (2007)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo
Thomas Von Hahn et al.
GASTROENTEROLOGY (2007)
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI
Marlene Dreux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
BD Lindenbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Treating viral hepatitis C: Efficacy, side effects, and complications
M. P. Manns et al.
GUT (2006)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
P Simmonds et al.
HEPATOLOGY (2005)
Complete replication of hepatitis C virus in cell culture
BD Lindenbach et al.
SCIENCE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
An interplay between hypervariable region 1 of the Hepatitis C Virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies
B Bartosch et al.
JOURNAL OF VIROLOGY (2005)
Robust hepatitis C virus infection in vitro
J Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection
D Lavillette et al.
JOURNAL OF VIROLOGY (2005)
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1
JC Meunier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neutralizing antibody response during acute and chronic hepatitis C virus infection
C Logvinoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vitro assay for neutralizing antibody to hepatitis C virus:: Evidence for broadly conserved neutralization epitopes
B Bartosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
HCV persistence and immune evasion in the absence of memory T cell help
A Grakoui et al.
SCIENCE (2003)
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
M Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
B Bartosch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Share Paper
